The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGamma Communications Regulatory News (GAMA)

Share Price Information for Gamma Communications (GAMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,460.00
Bid: 1,460.00
Ask: 1,464.00
Change: -36.00 (-2.41%)
Spread: 4.00 (0.274%)
Open: 1,494.00
High: 1,498.00
Low: 1,458.00
Prev. Close: 1,496.00
GAMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

27 Jan 2015 07:01

RNS Number : 1844D
Gamma Communications PLC
27 January 2015
 



 

27 January 2015

Gamma Communications plc

 

Post year end trading update

 

Gamma Communications plc ("Gamma"), a leading, technology based provider of communications services to the UK business market, is pleased to announce a trading update for the year ended 31 December 2014.

 

Group overview

 

Following our successful flotation on the Alternative Investment Market in October 2014, we are pleased to report that the Group's Revenue and Adjusted EBITDA* for the year ended 31 December 2014 is slightly ahead of the Board's original expectations. This reflects a strong demand in the business market for Gamma's portfolio of products. This positive performance was principally driven by the following factors:

 

· Growth in the number of channel partners in our indirect business from 650 to 730

· Significant contract wins in our direct sales business, which focuses on more complex solutions, including Oxford University and Hearst Magazines.

· Continued strong growth in both Gamma SIP Trunks and active seats on Gamma's Cloud PBX services

 

We have continued to successfully execute our corporate strategy of improving our revenue mix from lower margin traditional voice services to higher margin strategic services such as Cloud PBX, SIP and Inbound call control which have greater know-how and software content. At the same time, we have managed the structural decline in wholesale calls and lines ahead of the negative trend which has been a feature of the market for some years.

 

Acquisitions and Investments

 

In November, we finalised a £2.6m deferred consideration payment for our 2012 acquisition of Varidion Ltd, resulting in an aggregate consideration for the business of £3.6m - a 2.2x ebitda multiple. In addition we entered into new leases on two properties in London and Glasgow to cater for the continued expansion of the business.

 

Just prior to year end, the Group also made an opportunistic, but nonetheless strategic, acquisition of assets to strengthen its position in the growing market for converged fixed & mobile services and will update the market more fully on this at the time of our full year results.

 

Exceptional items & Share based payments

Exceptional items will be £2.1m, including £1.3m of IPO costs and £0.6m due to the change in the fair value of contingent consideration relating to the Varidion acquisition. Share Based Payment charges will be £3.4m that relate to options issued around the time of the flotation as well as the private company share options that vested as a consequence of the share capital reorganisation on IPO.

 

Cash

 

The Group continued to generate strong cash from its trading activities. The closing cash balance for the year was £13.4m compared to £14.6m at the end of the previous year as a consequence of the settlement of the deferred consideration of Varidion, the asset acquisition just prior to the year end and IPO related cash expenses.

The Directors expect to propose a dividend in line with the policy that was stated in the Admission document.

 

The results for the full year ended 31 December 2014 are expected to be released in late March 2015.

 

*Note: Adjusted EBITDA is stated before exceptional items and share based payment charges.

 

Bob Falconer, Chief Executive, commented on the results:

 

"We are very pleased with the performance of Gamma throughout 2014, the successful flotation on the AIM market in October, and the underpinning trends in the business. As a channel focused business, our growth continues to demonstrate the appetite that new partners have to join us and our existing partners have to work closely with us to take additional services to their customers.

 

We were also pleased that, for the third year in a row, we were recognised as one of the "The Sunday Times 100 Best Mid Companies to Work For 2015"."

 

Enquiries:

 

Gamma Communications +44 (0) 333 014 0000

Bob Falconer, Chief Executive

Andrew Belshaw, Group Finance Director

 

Investec Bank PLC +44 (0) 207 597 5970

NOMAD & Broker

Andrew Pinder, Dominic Emery, Patrick Robb

 

Tulchan Communications +44 (0) 207 353 4200

James Macey White

Tom Buchanan

 

 

Notes to Editors

Gamma is a rapidly growing, technology based, provider of communications services to the UK business market. Gamma's services, such as Cloud PBX, Inbound Call Control Services and SIP Trunking, are designed to meet the increasingly complex voice, data and mobility requirements of businesses, through the exploitation of its know-how and own intellectual property.

Gamma also provides services such as business-grade broadband, Ethernet and mobile and data services and, as a consequence of its history, has a substantial voice service capability. These services enable Gamma to provide a comprehensive range of communications services. 

Gamma has enjoyed strong organic revenue and EBITDA growth driven by high percentage of repeat revenues. The business has over 500 employees, of which 20% are employed in product development. It operates across six main locations - headquartered in Newbury - with offices in Fareham, Manchester, Glasgow, London & Budapest.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFVTLSIRFIE
Date   Source Headline
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:02 amRNSShare buyback programme
25th Mar 20247:01 amRNSFinal Results
25th Mar 20247:00 amRNSBoard Change and Committee Composition
22nd Mar 20245:20 pmRNSHolding(s) in Company
14th Mar 20247:30 amRNSDirector/PDMR Shareholding
1st Mar 20242:31 pmRNSTotal Voting Rights
14th Feb 20248:38 amRNSDirector/PDMR Shareholding
13th Feb 20248:00 amRNSSite visit for investors
1st Feb 20241:49 pmRNSTotal Voting Rights
17th Jan 20243:51 pmRNSHolding(s) in Company
16th Jan 20247:00 amRNSScheduled Trading Update
15th Jan 20244:46 pmRNSDirector/PDMR Shareholding
2nd Jan 202410:24 amRNSTotal Voting Rights
28th Dec 20234:10 pmRNSHolding(s) in Company
21st Dec 20235:34 pmRNSHolding(s) in Company
21st Dec 20235:33 pmRNSHolding(s) in Company
13th Dec 20235:35 pmRNSDirector/PDMR Shareholding
13th Dec 202312:34 pmRNSIssue of Equity
5th Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20234:13 pmRNSHolding(s) in Company
15th Nov 202310:31 amRNSDirector/PDMR Shareholding
9th Nov 20237:00 amRNSBlock listing Interim Review
1st Nov 202311:13 amRNSTotal Voting Rights
13th Oct 20233:59 pmRNSDirector/PDMR Shareholding
2nd Oct 20232:34 pmRNSTotal Voting Rights
14th Sep 20234:12 pmRNSIssue of Equity
14th Sep 20237:00 amRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSHalf-year Report
1st Sep 20237:00 amRNSTotal Voting Rights
25th Aug 20232:25 pmRNSHolding(s) in Company
15th Aug 20234:24 pmRNSDirector/PDMR Shareholding
2nd Aug 20237:00 amRNSTrading Statement
1st Aug 20237:00 amRNSTotal Voting Rights
13th Jul 20232:04 pmRNSDirector/PDMR Shareholding
3rd Jul 202312:11 pmRNSDirector/PDMR Shareholding
3rd Jul 202310:43 amRNSTotal Voting Rights
13th Jun 20235:03 pmRNSDirector/PDMR Shareholding
9th Jun 202312:35 pmRNSDirector/PDMR Shareholding
1st Jun 20232:19 pmRNSTotal Voting Rights - Replacement
1st Jun 202312:17 pmRNSTotal Voting Rights
30th May 202310:05 amRNSBlock Listing Application
25th May 20237:00 amRNSAppointment of Chair
23rd May 20234:12 pmRNSDirector/PDMR Shareholding
17th May 20235:08 pmRNSCommittee Composition
17th May 20234:25 pmRNSResult of AGM
17th May 20237:00 amRNSAGM Trading update
15th May 202311:46 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.